Mark R. Fesen
- Molecular Biology top 10%
- Infectious Diseases top 5%
- Virology top 2%
- Organic Chemistry top 10%
- Oncology
- Co-authors
- Yves PommierKurt W. KohnFrançois LeteurtreAbhijit MazumderGlenda KohlhagenJutta SchulzAkira FujimoriÉric Solary
- Topics
- HIV/AIDS drug development and treatment (9 papers)Cancer therapeutics and mechanisms (5 papers)Bioactive Compounds and Antitumor Agents (2 papers)
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- United StatesGermany
In The Last Decade
Mark R. Fesen
17 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 802
- Infectious Diseases 470
- Virology 392
- Organic Chemistry 307
- Oncology 186
Countries citing papers authored by Mark R. Fesen
This map shows the geographic impact of Mark R. Fesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Fesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Fesen more than expected).
Fields of papers citing papers by Mark R. Fesen
This network shows the impact of papers produced by Mark R. Fesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Fesen. The network helps show where Mark R. Fesen may publish in the future.
Co-authorship network of co-authors of Mark R. Fesen
This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Fesen. A scholar is included among the top collaborators of Mark R. Fesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Fesen. Mark R. Fesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 64 | |
| 4 | 3 | |
| 5 | 51 | |
| 6 | 21 | |
| 7 | 176 | |
| 8 | 0 | |
| 9 | 80 | |
| 10 | 163 | |
| 11 | 44 | |
| 12 | 196 | |
| 13 | Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compoundsbreakdown → | 292 |
| 14 | 43 | |
| 15 | 0 | |
| 16 | 42 | |
| 17 | 246 | |
| 18 | 64 | |
| 19 | 39 | |
| 20 | 1 |
About Mark R. Fesen
Mark R. Fesen is a scholar working on Toxicology, Infectious Diseases and Virology, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Cancer therapeutics and mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Virology (392 citations), Toxicology (94 citations) and Infectious Diseases (470 citations). Mark R. Fesen has collaborated with scholars based in United States and Germany. Frequent co-authors include Yves Pommier, Kurt W. Kohn, François Leteurtre, Abhijit Mazumder, Glenda Kohlhagen, Jutta Schulz, Akira Fujimori, Éric Solary, Macki Kaloga and Richard Bertrand. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.